Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous

Akin Izgi1, Cevat Kirma, Ali Cevat Tanalp

  • 1Department of Cardiology, Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital, Kartal, Istanbul, Turkey. akinizgi@hotmail.com

Coronary Artery Disease
|August 19, 2007
PubMed

Insights

High thrombus burden and long target lesions during primary percutaneous coronary intervention (PCI) predict distal embolization (DE). Distal embolization increases the risk of target vessel revascularization and short-term mortality in acute myocardial infarction (AMI) patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Distal embolization (DE) is a complication of percutaneous coronary intervention (PCI).
  • Predictors and outcomes of DE following primary PCI for acute myocardial infarction (AMI) require further investigation.

Purpose of the Study:

  • To identify clinical, angiographic, and procedural predictors of DE after primary PCI.
  • To assess the impact of DE on 30-day outcomes in AMI patients.

Main Methods:

  • Retrospective analysis of 212 consecutive AMI patients undergoing primary PCI.
  • Evaluation of angiographic and procedural data to identify DE predictors.
  • Comparison of 30-day outcomes between patients with and without DE.

Main Results:

  • DE occurred in 12.7% of patients.
  • Independent predictors of DE included high thrombus burden (OR=5.2) and long target lesion length >14.5 mm (OR=3.9).
  • DE was associated with increased risk of target vessel revascularization (26% vs. 5%) and short-term mortality (29.6% vs. 7.5%).

Conclusions:

  • High thrombus burden and long target lesions are significant predictors of DE during primary PCI.
  • DE is associated with adverse short-term outcomes, including increased mortality.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...